These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1349 related articles for article (PubMed ID: 11733361)

  • 21. Characterization of mutator phenotype in familial colorectal cancer patients not fulfilling amsterdam criteria.
    Kim JC; Lee KH; Ka IH; Koo KH; Roh SA; Kim HC; Yu CS; Kim TW; Chang HM; Gong GY; Kim JS
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6159-68. PubMed ID: 15448003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.
    Shin KH; Shin JH; Kim JH; Park JG
    Cancer Res; 2002 Jan; 62(1):38-42. PubMed ID: 11782355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extensive molecular screening for hereditary non-polyposis colorectal cancer.
    Dieumegard B; Grandjouan S; Sabourin JC; Le Bihan ML; Lefrère I; Bellefqih ; Pignon JP; Rougier P; Lasser P; Bénard J; Couturier D; Bressac-de Paillerets B
    Br J Cancer; 2000 Feb; 82(4):871-80. PubMed ID: 10732761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic testing for hereditary nonpolyposis colorectal cancer.
    Hoedema R; Monroe T; Bos C; Palmer S; Kim D; Marvin M; Luchtefeld M
    Am Surg; 2003 May; 69(5):387-91; discussion 391-2. PubMed ID: 12769209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical analysis and molecular genetic study of hereditary nonpolyposis colorectal cancer kindreds].
    Luo DC; Cai Q; Sun MH; Ni YZ; Tao CW; Chen ZJ; Shi DR
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):158-62. PubMed ID: 15062061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mismatch repair deficiency in sporadic synchronous colorectal cancer.
    Brueckl WM; Limmert T; Brabletz T; Guenther K; Jung A; Hermann K; Wiest GH; Kirchner T; Hohenberger W; Hahn EG; Wein A
    Anticancer Res; 2000; 20(6C):4727-32. PubMed ID: 11205208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microsatellite instability and hMLH1 and hMSH2 gene expression in Taiwanese hereditary nonpolyposis colorectal cancer.
    Wei SC; Shun CT; Tsai-Wu JJ; Wu CH; Sheu JC; Wang CY; Wong JM
    J Formos Med Assoc; 2004 May; 103(5):331-6. PubMed ID: 15216397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1.
    Thibodeau SN; French AJ; Cunningham JM; Tester D; Burgart LJ; Roche PC; McDonnell SK; Schaid DJ; Vockley CW; Michels VV; Farr GH; O'Connell MJ
    Cancer Res; 1998 Apr; 58(8):1713-8. PubMed ID: 9563488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer.
    Plevová P; Krepelová A; Papezová M; Sedláková E; Curík R; Foretová L; Navrátilová M; Novotný J; Zapletalová J; Palas J; Nieslanik J; Horácek J; Dvorácková J; Kolár Z
    Neoplasma; 2004; 51(4):275-84. PubMed ID: 15254659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsatellite Instability and hMLH1 and hMSH2 expression analysis in familial and sporadic colorectal cancer.
    Salahshor S; Koelble K; Rubio C; Lindblom A
    Lab Invest; 2001 Apr; 81(4):535-41. PubMed ID: 11304573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of the immunohistochemistry for hMLH1 and hMSH2 with detection of microsatellite instability to identify the kindreds with hereditary nonpolyposis colorectal cancer].
    Jin HY; Cui L; Meng RG; Liu F; Yan YD; Ding YJ; Yao H; Fu CG; Yu DH
    Zhonghua Wai Ke Za Zhi; 2003 Nov; 41(11):809-11. PubMed ID: 14703452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors.
    Marcus VA; Madlensky L; Gryfe R; Kim H; So K; Millar A; Temple LK; Hsieh E; Hiruki T; Narod S; Bapat BV; Gallinger S; Redston M
    Am J Surg Pathol; 1999 Oct; 23(10):1248-55. PubMed ID: 10524526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression.
    Scartozzi M; Bianchi F; Rosati S; Galizia E; Antolini A; Loretelli C; Piga A; Bearzi I; Cellerino R; Porfiri E
    J Clin Oncol; 2002 Mar; 20(5):1203-8. PubMed ID: 11870161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of cyclooxygenase-2 and relationship with mismatch repair gene and microsatellite instability in hereditary non-polyposis colorectal cancer].
    Zhang YH; Sheng JQ; Geng HG; Han M; Huang JS; Mu H; Han WL; Chen JG; Niu HL; Li AQ; Wu ZT; Li SR
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1377-81. PubMed ID: 19671325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
    Whelan AJ; Babb S; Mutch DG; Rader J; Herzog TJ; Todd C; Ivanovich JL; Goodfellow PJ
    Int J Cancer; 2002 Jun; 99(5):697-704. PubMed ID: 12115503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas.
    Koinuma K; Shitoh K; Miyakura Y; Furukawa T; Yamashita Y; Ota J; Ohki R; Choi YL; Wada T; Konishi F; Nagai H; Mano H
    Int J Cancer; 2004 Jan; 108(2):237-42. PubMed ID: 14639609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway.
    Llor X; Pons E; Xicola RM; Castells A; Alenda C; Piñol V; Andreu M; Castellví-Bel S; Payá A; Jover R; Bessa X; Girós A; Roca A; Gassull MA;
    Clin Cancer Res; 2005 Oct; 11(20):7304-10. PubMed ID: 16243801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of microsatellite testing and mismatch repair protein expression on the clinical interpretation of genetic testing in hereditary non-polyposis colorectal cancer.
    Ward R; Meldrum C; Williams R; Mokany E; Scott R; Turner J; Hawkins N; Burgess B; Groombridge C; Spigelman A
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):403-11. PubMed ID: 12200596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. hMLH1 and hMSH2 expression in human hepatocellular carcinoma.
    Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR
    Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 68.